Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2019 | 06-2018 | 06-2017 | 06-2016 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 96,072 | 126,150 | 76,086 | 104,476 | 107,735 |
| Depreciation Amortization | 78,171 | 64,463 | 60,036 | 42,764 | 37,226 |
| Income taxes - deferred | -13,582 | -46,716 | -3,433 | -2,624 | 1,304 |
| Accounts receivable | -15,000 | -2,700 | -19,686 | -22,981 | -11,747 |
| Accounts payable and accrued liabilities | 6,101 | 5,026 | 5,695 | 8,924 | 2,154 |
| Other Working Capital | -27,751 | 1,896 | -15,451 | -15,041 | -11,367 |
| Other Operating Activity | 57,608 | 22,248 | 40,474 | 28,639 | 14,054 |
| Operating Cash Flow | $181,619 | $170,367 | $143,721 | $144,157 | $139,359 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -21,896 | 27,819 | 3,010 | 776 | 13,466 |
| PPE Investments | -25,411 | -20,934 | -15,179 | -16,898 | -19,905 |
| Net Acquisitions | -289,492 | -67,851 | -253,785 | -91,423 | -420,102 |
| Purchase Of Investment | N/A | 21,574 | -40,000 | N/A | N/A |
| Other Investing Activity | 0 | 680 | 0 | -25 | 49 |
| Investing Cash Flow | $-336,799 | $-38,712 | $-305,954 | $-107,570 | $-426,492 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 580,000 | 55,000 | 368,500 | 77,000 | 163,000 |
| Common Stock Issued | 37,950 | 19,170 | 5,257 | 5,458 | 9,731 |
| Common Stock Repurchased | -15,405 | N/A | N/A | N/A | N/A |
| Dividend Paid | -48,364 | -47,973 | -47,325 | -47,607 | -47,107 |
| Other Financing Activity | -419,797 | -125,385 | -137,319 | -58,221 | -94,349 |
| Financing Cash Flow | $134,384 | $-99,188 | $189,113 | $-23,370 | $31,275 |
| Exchange Rate Effect | -308 | -2,089 | 495 | -3,512 | -8,178 |
| Beginning Cash Position | 121,990 | 91,612 | 64,237 | 54,532 | 318,568 |
| End Cash Position | 100,886 | 121,990 | 91,612 | 64,237 | 54,532 |
| Net Cash Flow | $-21,104 | $30,378 | $27,375 | $9,705 | $-264,036 |
| Free Cash Flow | |||||
| Operating Cash Flow | 181,619 | 170,367 | 143,721 | 144,157 | 139,359 |
| Capital Expenditure | -25,411 | -20,934 | -15,179 | -16,898 | -19,905 |
| Free Cash Flow | 156,208 | 149,433 | 128,542 | 127,259 | 119,454 |